FORM 8.3 - AON PLC - AMENDMENT

LONDON--()-- 

FORM 8.3

Amendment to Purchase

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in AON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 12 March 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

466,204

0.21%

1,792,884

0.79%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

106,445

0.05%

30,257

0.01%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

24,200

0.01%

24,200

0.01%

 

 

 

 

(4)

TOTAL:

 

 

 

 

596,849

0.26%

1,847,341

0.82%

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit
Purchase

3

228.1600 USD
Purchase

7

227.9700 USD
Purchase

8

227.9837 USD
Purchase

8

228.1437 USD
Purchase

10

228.0495 USD
Purchase

14

228.0550 USD
Purchase

19

228.0610 USD
Purchase

38

228.9257 USD
Purchase

72

228.0533 USD
Purchase

106

228.0019 USD
Purchase

185

229.3754 USD
Purchase

200

227.8951 USD
Purchase

200

228.2500 USD
Purchase

258

228.0800 USD
Purchase

300

227.9866 USD
Purchase

386

228.2818 USD
Purchase

504

228.1357 USD
Purchase

505

228.0420 USD
Purchase

600

228.0636 USD
Purchase

673

228.1030 USD
Purchase

725

228.0342 USD
Purchase

794

228.0434 USD
Purchase

802

228.2584 USD
Purchase

900

228.1616 USD
Purchase

939

228.1759 USD
Purchase

1,200

229.0000 USD
Purchase

1,219

228.0772 USD
Purchase

1,252

228.0775 USD
Purchase

1,271

228.0532 USD
Purchase

1,325

228.0845 USD
Purchase

1,793

228.0179 USD
Purchase

2,260

228.0582 USD
Purchase

3,801

228.0081 USD
Purchase

6,142

228.1302 USD
Purchase

11,359

228.3795 USD
Purchase

11,458

228.3577 USD
Purchase

15,043

228.0000 USD
Purchase

15,737

228.0480 USD
Purchase

25,197

228.1849 USD
Sale

2

228.1400 USD
Sale

3

228.0233 USD
Sale

4

228.1000 USD
Sale

7

229.4500 USD
Sale

12

229.5500 USD
Sale

100

227.8300 USD
Sale

100

228.2000 USD
Sale

142

227.5361 USD
Sale

166

229.3596 USD
Sale

172

228.3569 USD
Sale

300

227.9866 USD
Sale

600

228.3283 USD
Sale

1,203

228.9975 USD
Sale

1,259

228.0125 USD
Sale

1,715

228.3521 USD
Sale

2,131

228.1089 USD
Sale

2,241

228.0570 USD
Sale

2,634

228.1792 USD
Sale

3,897

228.0178 USD
Sale

8,735

228.0606 USD
Sale

9,346

228.4139 USD
Sale

10,233

228.3755 USD
Sale

11,449

228.0256 USD
Sale

15,934

228.0000 USD
Sale

35,717

228.1656 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 16 Mar 2021
Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options

Purchased

-1,200

220.0000

American

Jul 16, 2021

Call Options

Purchased

1,200

240.0000

American

Jul 16, 2021

Call Options

Purchased

23,000

220.0000

American

Jul 16, 2021

Put Options

Purchased

-23,000

200.0000

American

Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

Category Code: RET
Sequence Number: 732760
Time of Receipt (offset from UTC): 20210316T134525+0000

Contacts

BARCLAYS PLC

Contacts

BARCLAYS PLC